- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Bladder Urothelial Carcinoma
Total 25739 results
-
Istari Oncology, Inc.Active, not recruitingSolid Tumor | Bladder Cancer | Non-muscle-invasive Bladder CancerUnited States
-
AstraZenecaActive, not recruitingMetastatic Urothelial Cancer | Unresectable Locally Advanced Urothelial CancerUnited States, Italy, Spain, Canada, Hungary, Poland, Argentina, Thailand, Vietnam, Turkey, Korea, Republic of, Brazil, Czechia, India, Japan, Philippines, Russian Federation, China, Taiwan, Israel, Australia, Bulgaria
-
Huazhong University of Science and TechnologyRecruitingBladder Cancer | Non-Muscle-Invasive Bladder CancerChina
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Shanghai Xianxiang Medical Technology Co., Ltd.RecruitingNon-Muscle-Invasive Bladder Cancer (NMIBC)China
-
RenJi HospitalBeiGene; RemeGen Co., Ltd.RecruitingHER2 | Non-Muscle Invasive Bladder CancerChina
-
White River Junction Veterans Affairs Medical CenterMedical University of South Carolina; National Cancer Institute (NCI); University...RecruitingNon-muscle-invasive Bladder CancerUnited States
-
Al-Azhar UniversityRecruiting
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Recruiting
-
VA Office of Research and DevelopmentUniversity of California, DavisRecruiting
-
CHU de Quebec-Universite LavalCanadian Institutes of Health Research (CIHR)RecruitingNon-Muscle Invasive Bladder CancerCanada
-
Clinical Hospital Centre ZagrebActive, not recruitingNon-muscle-invasive Bladder CancerCroatia
-
Archivel Farma S.L.Fundació Institut Germans Trias i PujolCompletedHigh-Risk Non-Muscle-Invasive Bladder CancerSpain
-
National Cancer Institute (NCI)Not yet recruitingAdenocarcinoma of the Bladder | Squamous Cell Carcinoma of the Bladder | Testicular Germ Cell TumorsUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnRecurrent Bladder Cancer | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage III Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Ureter Cancer | Recurrent Urethral Cancer | Urethral Cancer Associated With Invasive Bladder Cancer | Localized Transitional Cell Cancer... and other conditions
-
Regina Elena Cancer InstituteRecruitingSurgery | Chemotherapy Effect | Muscle-Invasive Bladder CarcinomaItaly
-
National Cancer Institute (NCI)NeoImmuneTechWithdrawnBreast Carcinoma | Bladder Carcinoma | Colorectal AdenocarcinomaUnited States
-
GV20 TherapeuticsRecruitingCholangiocarcinoma | Non-small Cell Lung Cancer | Endometrial Carcinoma | Head and Neck Carcinoma | Cutaneous Melanoma | Solid Tumor, Adult | Refractory Cancer | Adenocarcinoma of the Rectum | Bladder Urothelial Carcinoma | Adenocarcinoma of the ColonUnited States
-
Mamta ParikhNational Cancer Institute (NCI)RecruitingStage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | Recurrent Non-Muscle Invasive Bladder CarcinomaUnited States
-
CG Oncology, Inc.RecruitingNon Muscle Invasive Bladder Cancer | High-grade Ta/ T1 Papillary Disease Bladder CancerUnited States, Korea, Republic of, Taiwan, Japan, Australia
-
Ractigen Therapeutics.RecruitingNon-Muscle-Invasive Bladder Cancer (NMIBC)Australia
-
Janssen Research & Development, LLCRecruitingNon-Muscle Invasive Bladder CancerUnited States, Israel
-
Shanghai Hengrui Pharmaceutical Co., Ltd.RecruitingHigh-risk Non-muscle Invasive Bladder CancerChina
-
Johns Hopkins UniversityRecruitingNon-Muscle Invasive Bladder CancerUnited States
-
Binhui Biopharmaceutical Co., Ltd.RecruitingNon-muscle-invasive Bladder CancerChina
-
ImmunityBio, Inc.Active, not recruitingNon Muscle Invasive Bladder CancerUnited States
-
University Teaching Hospital Hall in TirolSalzburger LandesklinikenRecruitingNeoplasms | Urogenital Neoplasms | Transitional Cell Carcinoma | Circulating Tumor Cell | Urinary Bladder NeoplasmAustria
-
Ankara Training and Research HospitalRecruitingBenign Prostatic Hyperplasia | Bladder Cancer | HematuriaTurkey
-
Endo PharmaceuticalsCompleted
-
Ectin Research ABNot yet recruitingMetastatic Urothelial CancerSweden
-
Matthew GalskyIcahn School of Medicine at Mount Sinai; AstraZenecaCompletedMetastatic Urothelial CancerUnited States
-
University Hospital, GhentCompletedMetastatic Urothelial CancerBelgium
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingBladder CarcinomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingBladder CarcinomaUnited States
-
National Cancer Institute (NCI)RecruitingUrogenital Neoplasms | Bladder Cancer | Urothelial Cancer | Genitourinary Cancer | Urogenital CancerUnited States
-
Emory UniversityCompletedUrolithiasis | Urothelial Carcinoma | Hydronephrosis | Ureteral StrictureUnited States
-
Prokarium LtdRecruitingA Phase 1/1b Study of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder Cancer (PARADIGM-1)NMIBC | Non Muscle Invasive Bladder Cancer | High Risk NMIBCUnited States
-
Fidia Farmaceutici s.p.a.TerminatedNon-muscle Invasive Bladder Cancer (NMIBC)Italy
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...RecruitingMelanoma | Renal Cell Carcinoma | Breast Cancer | NSCLC | Urinary Bladder Cancer | Squamous Cell Carcinoma of Head and Neck | Small Cell CarcinomaItaly
-
SURGE TherapeuticsRecruitingNon-muscle-invasive Bladder CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteRecruitingNon-muscle Invasive Bladder CancerUnited States
-
University of BernSpitalzentrum BielNot yet recruitingBladder Cancer | Non-muscle Invasive Bladder Cancer | Low-riskSwitzerland
-
Protara TherapeuticsRecruitingNon-muscle Invasive Bladder CancerUnited States, Ukraine
-
Janssen Research & Development, LLCRecruitingBladder CancerUnited States, Belgium, Korea, Republic of, Italy, Taiwan, China, United Kingdom, Germany, France, Argentina, Brazil, Poland, Spain, Czechia, Japan, Netherlands, India, Canada, Mexico, Australia, Portugal
-
Protara TherapeuticsRecruitingNon-muscle Invasive Bladder CancerUnited States, Moldova, Republic of, Romania, Ukraine
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCRecruiting
-
ImmunityBio, Inc.Active, not recruiting
-
PharmalinkActive, not recruitingNon-muscle-invasive Bladder CancerSpain
-
University of OklahomaEMD SeronoCompletedBladder CancerUnited States
-
Jørgen Bjerggaard JensenCepheidActive, not recruitingNon-muscle Invasive Bladder Cancer | Urinary BiomarkerDenmark
-
Mayo ClinicRecruitingNon-muscle Invasive Bladder CancerUnited States